The salivary tip of the p53 mutagenesis iceberg: Novel insights

Cancer Biomarkers

Volumn 5, Issue 1, 2009, Pages 23-31

  Ben Izhak, Ofer ^a   Laster, Zvi ^b   Akrish, Sharon ^a   Muska, Egon ^b   Gan, Shlomit ^c   Nagler, Rafael M ^a,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Poriya Hospital   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer; Malignancies; p53; Prognosis; Salivary glands

Indexed keywords

HEPARIN LYASE; PROTEIN P53;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; MUTATIONAL ANALYSIS; NICK END LABELING; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MUTAGENESIS; MUTATION; NEOPLASM STAGING; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 61449161270     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0567     Document Type: Article

References (26)

1. L.D. Attardi, S.W. Lowe, J. Brugarolas and T. Jacks. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis, EMBO J 15 (1996), 3693-3701.
2. X. Xie, O.P. Clausen, P. De Angelis and M. Boysen, The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue, Cancer 86 (1999), 913-920.
3. D. Ravi, K. Ramadas, B.S. Mathew, K.R. Nalinakumari, M.K. Nair and M.R. Pillai, De novo programmed cell death in oral cancer, Histopathology 34 (1999), 241-249.
4. G. Selivanova and K.G. Wiman, Reactivation of mutant p53: Molecular mechanisms and therapeutic potential, Oncogene 26 (2007), 2243-2254.
5. C.M. Eneroth, Salivary gland tumors in the parotid gland, submandibular gland and the palate region, Cancer 27 (1971), 1415-1418.
6. J.W. Eveson and R.A. Cawson, Salivary gland tumors. a review of 2410 cases with particular reference to histological types, site, age and sex distribution, J Pathol 146 (1985), 51-58.
7. R.H. Spiro and S. Dubner, Salivary gland tumors, Curr Opin Oncol 2 (1990), 589-595.
8. M.E. Johns and M.M. Goldsmith, Incidence, diagnosis and classification of salivary gland tumors. Part 1, Oncology (Williston Park) 3 (1989), 47-56.
9. J.G. Batsakis, Salivary gland neoplasia: An outcome of modified morphogenesis and cytodifferentiation, Oral Surg Oral Med Oral Pathol 49 (1980), 229-232.
10. I. Dardick and A.W.P. van Nostrand, Morphogenesis of salivary gland tumors. A prerequisite to improving classification, Pathol Annu 22(pt 1) (1987), 1-53.
11. M.E. Johns and M. Goldsmith, Current management of salivary gland tumors. Part 2, Oncology (Williston Park) 3 (1989), 85-99.
12. J.G. Batsakis, J.A. Regezi, M.A. Luna and A.K. El-Naggar, Histogenesis of salivary gland neoplasms: A postulate with prognostic implications, J Laryngol Otol 103 (1989), 939-944.
13. I. Dardick, Histogenesis and morphogenesis of salivary gland neoplasms, in: Surgical Pathology of the Salivary Gland, Saunders: Philadelphia, 1991, pp. 108-128.
14. C.J. OflBrien, S.J. Soong, G.A. Herrera, M.M. Urist and W.A. Maddox, Malignant salivary tumors: Analysis of prognostic factors and survival, Head Neck Surg 9 (1986), 82-92.
15. L. Tran, A. Sadeghi, D. Hanson, G. Juillard, R. Mackintosh, T.C. Calcaterra and R.G. Parker, Major salivary gland tumors: Treatment results and prognostic factors, Laryngoscope 96 (1986), 1139-1144.
16. P. Hermanek, R.V.P. Hutter, L.H. Sobin, G. Wagner and C. Wittekind, TNM Atlas, Springer: New York, 1997, 59-63.
17. J.G. Batsakis, Surgical excision margins: A pathologist's persepctive, Adv Anat Pathol 6 (1999), 140-148.
18. R.M. Nagler, M. Barak, H. Ben-Aryeh, M. Peled, M. Filatov and D. Laufer, Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma, Cancer 35 (1999), 1018-1025.
19. O. Ben Izhak, V. Kaplan-Cohen, N. Ilan, S. Gan, I. Vlodavsky and R. Nagler, Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival, Neoplasia 8 (2006), 879-884.
20. O. Ben-Izhak, Z. Laster, S. Araidy and R.M. Nagler, TUNEL - an efficient predicot of salivary malignancies, Br J Cancer 96 (2007), 1101-1106.
21. R.M. Nagler, H. Kerner, S. Ben-Eliezer, I. Minkov and O. Ben-Itzhak, Prognostic role of apoptopic, BCL-2, C-ERBB-2 and P53 tumor markers in salivary gland malignancies, Oncology 64 (2003), 389-398.
22. R.M. Nagler and D. Laufer, Tumors of the major and minor salivary glands: Review of 25 years of experience, Anticancer Res 17 (1997), 701-707.
23. D. Knezevic, W. Zhang, P.J. Rochette and D.E. Brash, BCL-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling, Proc Natl Acad Sci USA 104 (2007), 11286-11291.
24. D. Strianese, G. Baldi, S. Staibano, A. Baldi, G. De Rosa, F. Tranfa and G. Bonavolonta, Expression of apoptosis-related markers in malignant epithelial tumors of the lacrimal gland and their relation to clinical outcome, Br J Ophthalmol 91 (2007), 1239-1243.
25. N. Ilan, M. Elkin and I. Vlodavsky, Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis, Int J Biochem Cell Biol 38 (2006), 2018-2039.
26. L. Baraz, Y. Haupt, M. Elkin, T. Peretz and I. Vlodavsky, Tumor suppressor p53 regulates heparanase gene expression, Oncogene 25 (2006), 3939-3947.